Friday, March 11, 2011

Seroquel: $68.5 Million Settlement to U.S. States Over Seroquel Marketing

Seroquel-tablets, 100 and 25 mgImage via Wikipedia
In a lawsuit against the makers of Seroquel, Astra Zeneca - it was claimed that the company marketed Seroquel for uses that weren’t approved by the U.S. Food and Drug Administration, the federal and state governments claimed. AstraZeneca promoted the drug, approved for schizophrenia and bipolar disorder, for dementia, depression and anxiety in violation of federal drug rules, according to the states.

The company agreed to pay $68.5 million to 37 U.S. states and the District of Columbia to resolve allegations that the company deceptively marketed its anti-psychotic drug Seroquel.

 Link here.